Anti-LAG-3 Antibody-PE (6Z541)

Name: Anti-LAG-3 Antibody-PE (6Z541)
Brand: TargetMol
SKU: TMAY-02828P
Rating: 4.5 (1 reviews)

(Synonyms: lymphocyte-activation gene 3, LAG-3, CD223) Copy Product Info

🥰Excellent

Synonyms: lymphocyte-activation gene 3, LAG-3, CD223

Catalog No. TMAY-02828P Copy Product Info

🥰Excellent

Anti-LAG-3 Antibody-PE (6Z541) is a PE-conjugated Mouse antibody targeting LAG-3. Anti-LAG-3 Antibody-PE (6Z541) can be used in FCM.

Pack Size	Price	USA Stock	Global Stock	Quantity
25 T	$81	7-10 days	7-10 days
100 T	$175	7-10 days	7-10 days

For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)

Add to Cart

Add to Quotation

For research use only—not for human use. No sales to individuals. Use as intended only.

Questions

Resource Download

Bioactivity

Description	Anti-LAG-3 Antibody-PE (6Z541) is a PE-conjugated Mouse antibody targeting LAG-3. Anti-LAG-3 Antibody-PE (6Z541) can be used in FCM.
Synonyms	lymphocyte-activation gene 3, LAG-3, CD223
Ig Type	Mouse IgG1
Clone	6Z541
Reactivity	Human
Specificity	Human LAG-3

Application	FCM
Recommended Dose	5 μL/Test, 0.1 mg/mL
Antibody Type	Monoclonal
Host Species	Mouse
Construction	This product is a recombinant monoclonal antibody expressed from HEK293 cells, and conjugated with PE under optimum conditions, the unreacted PE was removed.
Purification	Protein A
Appearance	Liquid
Formulation	PBS solution containing 0.5% BSA and 0.03%ProClin300
Research Background	LAG3 (Lymphocyte Activating 3) is a Protein Coding gene. 2 alternatively spliced human isoforms have been reported. LAG3, also known as CD223 and Lymphocyte activation gene 3, belongs to the immunoglobulin (Ig) superfamily. The LAG3 gene contains 8 exons. It is selectively expressed in activated T and NK cells. LAG3 contains 4 extracellular Ig-like domains and has a negative regulatory function in T cells. It also acts as a new marker of T cell-induced B cell activation. As a soluble molecule, LAG3 activates antigen-presenting cells through MHC class II signaling, leading to increased antigen-specific T-cell responses in vivo. Diseases associated with LAG3 include Smoldering Myeloma and Kyphoscoliotic Heart Disease.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint TargetsImmunotherapyTargeted Therapy